Business News • PR NewsWire • Registration Details for Immunovia's Second Webinar in the Series on IMMray™ PanCan-d: Commercial Test Model Study & Update on Launch Activities

Registration Details for Immunovia's Second Webinar in the Series on IMMray™ PanCan-d: Commercial Test Model Study & Update on Launch Activities

Registration Details for Immunovia's Second Webinar in the Series on IMMray™ PanCan-d: Commercial Test Model Study & Update on Launch Activities

LUND, Sweden, Aug. 28, 2020 /PRNewswire/ -- Immunovia AB (publ) ("Immunovia"), today announced that the company will be hosting the second webinar in the series on Immunovia's IMMray™ PanCan-d. This second webinar will cover the results of the Commercial Test Model Study (link to pr) and...

View More : https://www.prnewswire.com:443/news-releases/registration-details-for-immunovias-second-webinar-in-the-series-on-immray-...

Releted News by prnewswire

Nanoform Finland PLC, 2020 Half Year Financial Report, 28 August 2020 At 8:10 Am EEST

AIDA Cruises Will Resume Cruise Operations with Fall and Winter Voyages

Investment in nickel expansion at Boliden Harjavalta

Registration Details for Immunovia's Second Webinar in the Series on IMMray™ PanCan-d: Commercial Test Model Study & Update on Launch Activities

Borr Drilling Limited Announces Preliminary Results for the Second Quarter of 2020

(CACC) Investor Alert: Johnson Fistel Investigates Credit Acceptance; Encourages Investors Suffering Losses to Contact Firm